Several U.S. Food and Drug Administration (FDA) employees involved in the review of Tesla (NASDAQ: TSLA) Chief, Elon Musk’s private brain implant company, Neuralink, were dismissed over the weekend.
DOGE Reportedly Fires FDA Staff Reviewing Elon Musk’s Neuralink: ‘We Should Be Worried About The Whole Trial,’ Says Former Official
